PPHLN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.358600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.171600E-01
Normal-vs-Stage2
2.407400E-01
Normal-vs-Stage3
1.483810E-01
Normal-vs-Stage4
1.769630E-01
Stage1-vs-Stage2
9.878400E-01
Stage1-vs-Stage3
3.021600E-01
Stage1-vs-Stage4
8.961800E-01
Stage2-vs-Stage3
2.604600E-01
Stage2-vs-Stage4
9.333000E-01
Stage3-vs-Stage4
3.712800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.494000E-01
Normal-vs-AfricanAmerican
2.768200E-01
Normal-vs-Asian
1.918610E-01
Caucasian-vs-AfricanAmerican
7.985600E-01
Caucasian-vs-Asian
3.193000E-01
AfricanAmerican-vs-Asian
7.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.625600E-01
Normal-vs-Female
2.243200E-01
Male-vs-Female
6.082800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.881400E-01
Normal-vs-Age(41-60Yrs)
4.726800E-01
Normal-vs-Age(61-80Yrs)
1.845780E-01
Normal-vs-Age(81-100Yrs)
5.933500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.067200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.245400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.948400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.255500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.504200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.401820E-01
Normal-vs-Daily Drinker
5.129800E-02
Normal-vs-Weekly Drinker
2.278400E-01
Normal-vs-Occasional Drinker
8.823000E-01
Normal-vs-Social Drinker
9.234300E-02
Non Drinker-vs-Daily Drinker
6.138000E-01
Non Drinker-vs-Weekly Drinker
9.638200E-01
Non Drinker-vs-Occasional Drinker
5.580000E-03
Non Drinker-vs-Social Drinker
8.604000E-01
Daily Drinker-vs-Weekly Drinker
7.289000E-01
Daily Drinker-vs-Occasional Drinker
8.826900E-04
Daily Drinker-vs-Social Drinker
4.889800E-01
Weekly Drinker-vs-Occasional Drinker
2.704200E-02
Weekly Drinker-vs-Social Drinker
8.549800E-01
Occasional Drinker-vs-Social Drinker
9.938000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.349800E-01
Normal-vs-Grade 2
5.270000E-01
Normal-vs-Grade 3
5.300600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.761200E-01
Grade 1-vs-Grade 3
7.531800E-01
Grade 1-vs-Grade 4
1.349800E-01
Grade 2-vs-Grade 3
9.430600E-01
Grade 2-vs-Grade 4
5.270000E-01
Grade 3-vs-Grade 4
5.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.623420E-01
Normal-vs-NonDiabetic
1.947800E-01
Diabetic-vs-NonDiabetic
6.983000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.583800E-02
Normal-vs-NoPancreatitis
2.130200E-01
Pancreatitis-vs-NoPancreatitis
1.813160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.708610E-01
Normal-vs-N1
2.606200E-01
N0-vs-N1
9.246600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.371600E-01
Normal-vs-TP53-NonMutant
3.204600E-01
TP53-Mutant-vs-TP53-NonMutant
3.215800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
